Literature DB >> 23165704

Human pericytes for ischemic heart repair.

Chien-Wen Chen1, Masaho Okada, Jonathan D Proto, Xueqin Gao, Naosumi Sekiya, Sarah A Beckman, Mirko Corselli, Mihaela Crisan, Arman Saparov, Kimimasa Tobita, Bruno Péault, Johnny Huard.   

Abstract

Human microvascular pericytes (CD146(+)/34(-)/45(-)/56(-)) contain multipotent precursors and repair/regenerate defective tissues, notably skeletal muscle. However, their ability to repair the ischemic heart remains unknown. We investigated the therapeutic potential of human pericytes, purified from skeletal muscle, for treating ischemic heart disease and mediating associated repair mechanisms in mice. Echocardiography revealed that pericyte transplantation attenuated left ventricular dilatation and significantly improved cardiac contractility, superior to CD56+ myogenic progenitor transplantation, in acutely infarcted mouse hearts. Pericyte treatment substantially reduced myocardial fibrosis and significantly diminished infiltration of host inflammatory cells at the infarct site. Hypoxic pericyte-conditioned medium suppressed murine fibroblast proliferation and inhibited macrophage proliferation in vitro. High expression by pericytes of immunoregulatory molecules, including interleukin-6, leukemia inhibitory factor, cyclooxygenase-2, and heme oxygenase-1, was sustained under hypoxia, except for monocyte chemotactic protein-1. Host angiogenesis was significantly increased. Pericytes supported microvascular structures in vivo and formed capillary-like networks with/without endothelial cells in three-dimensional cocultures. Under hypoxia, pericytes dramatically increased expression of vascular endothelial growth factor-A, platelet-derived growth factor-β, transforming growth factor-β1 and corresponding receptors while expression of basic fibroblast growth factor, hepatocyte growth factor, epidermal growth factor, and angiopoietin-1 was repressed. The capacity of pericytes to differentiate into and/or fuse with cardiac cells was revealed by green fluorescence protein labeling, although to a minor extent. In conclusion, intramyocardial transplantation of purified human pericytes promotes functional and structural recovery, attributable to multiple mechanisms involving paracrine effects and cellular interactions.
Copyright © 2012 AlphaMed Press.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23165704      PMCID: PMC3572307          DOI: 10.1002/stem.1285

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  48 in total

Review 1.  Cardiac cell therapy: lessons from clinical trials.

Authors:  Philippe Menasche
Journal:  J Mol Cell Cardiol       Date:  2010-06-30       Impact factor: 5.000

2.  Understanding abnormalities in vascular specification and remodeling.

Authors:  Josephine M Enciso; Karen K Hirschi
Journal:  Pediatrics       Date:  2005-07       Impact factor: 7.124

3.  Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature.

Authors:  Patrick Au; Joshua Tam; Dai Fukumura; Rakesh K Jain
Journal:  Blood       Date:  2008-02-06       Impact factor: 22.113

Review 4.  Cell therapies for therapeutic angiogenesis: back to the bench.

Authors:  Daniel P Sieveking; Martin K C Ng
Journal:  Vasc Med       Date:  2009-05       Impact factor: 3.239

Review 5.  Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair.

Authors:  Yufang Shi; Gangzheng Hu; Juanjuan Su; Wenzhao Li; Qing Chen; Peishun Shou; Chunliang Xu; Xiaodong Chen; Yin Huang; Zhexin Zhu; Xin Huang; Xiaoyan Han; Ningxia Xie; Guangwen Ren
Journal:  Cell Res       Date:  2010-04-06       Impact factor: 25.617

6.  Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction.

Authors:  Céline Mias; Olivier Lairez; Elodie Trouche; Jérome Roncalli; Denis Calise; Marie-Hélène Seguelas; Catherine Ordener; Marie-Dominique Piercecchi-Marti; Nathalie Auge; Anne Negre Salvayre; Philippe Bourin; Angelo Parini; Daniel Cussac
Journal:  Stem Cells       Date:  2009-11       Impact factor: 6.277

Review 7.  Proinflammatory cytokine effects on mesenchymal stem cell therapy for the ischemic heart.

Authors:  Aaron M Abarbanell; Arthur C Coffey; John W Fehrenbacher; Daniel J Beckman; Jeremy L Herrmann; Brent Weil; Daniel R Meldrum
Journal:  Ann Thorac Surg       Date:  2009-09       Impact factor: 4.330

Review 8.  The immune system and cardiac repair.

Authors:  Nikolaos G Frangogiannis
Journal:  Pharmacol Res       Date:  2008-06-24       Impact factor: 7.658

9.  Perivascular stem cells: a prospectively purified mesenchymal stem cell population for bone tissue engineering.

Authors:  Aaron W James; Janette N Zara; Xinli Zhang; Asal Askarinam; Raghav Goyal; Michael Chiang; Wei Yuan; Le Chang; Mirko Corselli; Jia Shen; Shen Pang; David Stoker; Ben Wu; Kang Ting; Bruno Péault; Chia Soo
Journal:  Stem Cells Transl Med       Date:  2012-06-11       Impact factor: 6.940

10.  Differentiation and migration properties of human foetal umbilical cord perivascular cells: potential for lung repair.

Authors:  Tiziana Montemurro; Gabriella Andriolo; Elisa Montelatici; Gaia Weissmann; Mihaela Crisan; Maria Rosa Colnaghi; Paolo Rebulla; Fabio Mosca; Bruno Péault; Lorenza Lazzari
Journal:  J Cell Mol Med       Date:  2011-04       Impact factor: 5.310

View more
  114 in total

1.  Controlled dual delivery of fibroblast growth factor-2 and Interleukin-10 by heparin-based coacervate synergistically enhances ischemic heart repair.

Authors:  William C W Chen; Brandon G Lee; Dae Woo Park; Kyobum Kim; Hunghao Chu; Kang Kim; Johnny Huard; Yadong Wang
Journal:  Biomaterials       Date:  2015-09-02       Impact factor: 12.479

2.  Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.

Authors:  Giuliana Castello Coatti; Miriam Frangini; Marcos C Valadares; Juliana Plat Gomes; Natalia O Lima; Natale Cavaçana; Amanda F Assoni; Mayra V Pelatti; Alexander Birbrair; Antonio Carlos Pedroso de Lima; Julio M Singer; Francisco Marcelo M Rocha; Giovani Loiola Da Silva; Mario Sergio Mantovani; Lucia Inês Macedo-Souza; Merari F R Ferrari; Mayana Zatz
Journal:  Stem Cell Rev Rep       Date:  2017-10       Impact factor: 5.739

3.  Induction of Perivascular Neural Stem Cells and Possible Contribution to Neurogenesis Following Transient Brain Ischemia/Reperfusion Injury.

Authors:  Masayo Nakata; Takayuki Nakagomi; Mitsuyo Maeda; Akiko Nakano-Doi; Yoshihiro Momota; Tomohiro Matsuyama
Journal:  Transl Stroke Res       Date:  2016-06-29       Impact factor: 6.829

4.  The impact of skeletal muscle contraction on CD146+Lin- pericytes.

Authors:  Svyatoslav Dvoretskiy; Koyal Garg; Michael Munroe; Yair Pincu; Ziad S Mahmassani; Charlotte Coombs; Brent Blackwell; Gabriela Garcia; Garret Waterstradt; Isaac Lee; Jenny Drnevich; Justin S Rhodes; Marni D Boppart
Journal:  Am J Physiol Cell Physiol       Date:  2019-08-21       Impact factor: 4.249

5.  Decellularized neonatal cardiac extracellular matrix prevents widespread ventricular remodeling in adult mammals after myocardial infarction.

Authors:  Zhouguang Wang; Daniel W Long; Yan Huang; William C W Chen; Kang Kim; Yadong Wang
Journal:  Acta Biomater       Date:  2019-01-30       Impact factor: 8.947

Review 6.  Cellular Based Strategies for Microvascular Engineering.

Authors:  Srinivas V Koduru; Ashley N Leberfinger; Denis Pasic; Anoosha Forghani; Shane Lince; Daniel J Hayes; Ibrahim T Ozbolat; Dino J Ravnic
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

7.  How Plastic Are Pericytes?

Authors:  Alexander Birbrair; Isabella da Terra Borges; Isadora Fernandes Gilson Sena; Gregório Guilherme Almeida; Lindolfo da Silva Meirelles; Ricardo Gonçalves; Akiva Mintz; Osvaldo Delbono
Journal:  Stem Cells Dev       Date:  2017-06-13       Impact factor: 3.272

Review 8.  Potential clinical benefits of cell therapy in coronary heart disease: an update.

Authors:  Vincenzo Grimaldi; Alberto Zullo; Francesco Donatelli; Francesco Paolo Mancini; Francesco Cacciatore; Claudio Napoli
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

Review 9.  A role for pericytes in coronary no-reflow.

Authors:  Fergus M O'Farrell; David Attwell
Journal:  Nat Rev Cardiol       Date:  2014-04-29       Impact factor: 32.419

10.  Smooth Muscle Progenitor Cells Derived From Human Pluripotent Stem Cells Induce Histologic Changes in Injured Urethral Sphincter.

Authors:  Yanhui Li; Yan Wen; Zhe Wang; Yi Wei; Prachi Wani; Morgaine Green; Ganesh Swaminathan; Anand Ramamurthi; Renee Reijo Pera; Bertha Chen
Journal:  Stem Cells Transl Med       Date:  2016-07-26       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.